📊 AMTX Key Takeaways
Is Aemetis, Inc. (AMTX) a Good Investment?
AEMETIS exhibits severe financial distress with negative stockholders equity of -$306.8M, indicating liabilities exceed assets after accounting for equity. The company is unprofitable with a -39% net margin, negative gross margin, and severely constrained liquidity (0.07x current ratio) while burning cash operationally relative to capital expenditure requirements. Fundamental business economics are broken and require substantial operational or structural restructuring to survive.
Aemetis shows severely stressed fundamentals: revenue is shrinking sharply, gross margin has turned negative, and operating and net losses remain very large relative to sales. Financial health is especially weak, with negative equity, extremely poor liquidity, weak interest coverage, and negative free cash flow, which together suggest a high dependence on external financing despite a modest improvement in net loss and positive operating cash flow.
Why Buy Aemetis, Inc. Stock? AMTX Key Strengths
- Positive operating cash flow of $3.3M suggests core operations generated some cash despite massive net losses
- Revenue base of $197.6M indicates established market presence in industrial chemicals sector
- 5 Form 4 insider filings suggest active management engagement with the company
- Operating cash flow was positive at $3.26M
- Net loss and diluted EPS improved year over year
- The business still generates meaningful revenue scale at $197.63M
AMTX Stock Risks: Aemetis, Inc. Investment Risks
- Negative stockholders equity of -$306.8M means company is technically insolvent from an accounting perspective
- Critical liquidity crisis with current ratio of 0.07x and only $4.9M cash against substantial liabilities
- Operating model fundamentally broken: negative gross margin means revenue-generating activities lose money before operating expenses
- Massive net losses of -$77M with negative ROA of -29.6% indicate asset destruction
- Long-term debt of $63.9M represents 13.6x annual cash available from operations
- Free cash flow of -$22.7M and -11.5% FCF margin indicates capital allocation is negative value-destroying
- Revenue declined 26.2% year over year, indicating weak growth quality
- Liquidity is critically weak with a 0.07x current ratio and 0.04x quick ratio
- Negative stockholders equity and negative free cash flow signal balance sheet stress and financing risk
Key Metrics to Watch
- Stockholders equity trajectory - movement toward positive territory or deeper insolvency
- Gross margin - must turn positive for business to be viable
- Operating cash flow sustainability - whether positive $3.3M can be maintained or deteriorates
- Debt refinancing ability - critical given low liquidity and negative equity position
- Revenue stabilization - whether -26.2% YoY decline continues or stabilizes
- Gross margin and operating margin recovery
- Liquidity runway including cash balance, current ratio, and free cash flow
Aemetis, Inc. (AMTX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
AMTX Profit Margin, ROE & Profitability Analysis
AMTX vs Materials Sector: How Aemetis, Inc. Compares
How Aemetis, Inc. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Aemetis, Inc. Stock Overvalued? AMTX Valuation Analysis 2026
Based on fundamental analysis, Aemetis, Inc. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Aemetis, Inc. Balance Sheet: AMTX Debt, Cash & Liquidity
AMTX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Aemetis, Inc.'s revenue has shown modest growth of 4% over the 5-year period. The most recent EPS of $-1.91 indicates the company is currently unprofitable.
AMTX Revenue Growth, EPS Growth & YoY Performance
AMTX Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $59.2M | -$17.9M | $-0.37 |
| Q2 2025 | $52.2M | -$23.4M | $-0.41 |
| Q1 2025 | $42.9M | -$24.2M | $-0.47 |
| Q3 2024 | $68.7M | -$17.9M | $-0.38 |
| Q2 2024 | $45.1M | -$24.2M | $0.66 |
| Q1 2024 | $2.2M | -$24.2M | $-0.58 |
| Q3 2023 | $68.7M | N/A | $-0.56 |
| Q2 2023 | $45.1M | -$209.0K | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Aemetis, Inc. Dividends, Buybacks & Capital Allocation
AMTX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Aemetis, Inc. (CIK: 0000738214)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AMTX
What is the AI rating for AMTX?
Aemetis, Inc. (AMTX) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 94% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AMTX's key strengths?
Claude: Positive operating cash flow of $3.3M suggests core operations generated some cash despite massive net losses. Revenue base of $197.6M indicates established market presence in industrial chemicals sector. ChatGPT: Operating cash flow was positive at $3.26M. Net loss and diluted EPS improved year over year.
What are the risks of investing in AMTX?
Claude: Negative stockholders equity of -$306.8M means company is technically insolvent from an accounting perspective. Critical liquidity crisis with current ratio of 0.07x and only $4.9M cash against substantial liabilities. ChatGPT: Revenue declined 26.2% year over year, indicating weak growth quality. Liquidity is critically weak with a 0.07x current ratio and 0.04x quick ratio.
What is AMTX's revenue and growth?
Aemetis, Inc. reported revenue of $197.6M.
Does AMTX pay dividends?
Aemetis, Inc. does not currently pay dividends.
Where can I find AMTX SEC filings?
Official SEC filings for Aemetis, Inc. (CIK: 0000738214) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AMTX's EPS?
Aemetis, Inc. has a diluted EPS of $-1.28.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AMTX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Aemetis, Inc. has a STRONG SELL rating with 94% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AMTX stock overvalued or undervalued?
Valuation metrics for AMTX: ROE of N/A (sector avg: 14%), net margin of -39.0% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy AMTX stock in 2026?
Our dual AI analysis gives Aemetis, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AMTX's free cash flow?
Aemetis, Inc.'s operating cash flow is $3.3M, with capital expenditures of $26.0M. FCF margin is -11.5%.
How does AMTX compare to other Materials stocks?
Vs Materials sector averages: Net margin -39.0% (avg: 10%), ROE N/A (avg: 14%), current ratio 0.07 (avg: 1.6).